The Müllerian inhibitor and mammalian sexual development
- 29 November 1995
- journal article
- Published by The Royal Society in Philosophical Transactions Of The Royal Society B-Biological Sciences
- Vol. 350 (1333) , 285-289
- https://doi.org/10.1098/rstb.1995.0163
Abstract
The elegant embryological experiments of Jost demonstrated the existence of a foetal testicular factor that is required to cause the regression of the Müllerian duct system, the anlagen of the uterus, oviducts and upper portion of the vagina, during male sexual development. The Müllerian inhibitor currently known as Müllerian-inhibiting substance (MIS) or anti-Müllerian hormone (AMH), is a member of the transforming growth factor-β (TGF-β) family of growth and differentiation factors. The genetic manipulation of the mouse germline has lead to the generation of animal models for MIS function. Female transgenic mice that chronically express MIS during embryogenesis are born without a uterus or oviducts and their ovaries lose germ cells and degenerate, recapitulating the phenotype of the bovine freemartin. Some male transgenic mice from very high MIS-expressing lines are feminized, suggesting alterations in androgen biosynthesis. Male mice homozygous for a targeted mutation of the MIS gene develop as male pseudohermaphrodites with both male (testes and Wolffian duct-derived) and female (Müllerian duct-derived) reproductive organs. Most are infertile because the development of two reproductive systems physically blocks the exit of sperm from these males. In addition, Leydig cell hyperplasia is detected in a proportion of these males and in one case a Leydig cell tumour was found. Recently, a gene encoding a TGF-β family type II Ser/Thr kinase membrane-bound receptor has been isolated that is expressed in both male and female gonads and in the mesenchyme surrounding the Müllerian ducts during embryogenesis. These findings suggest that MIS-mediated Müllerian duct regression occurs indirectly through mesenchymal tissue. A targeted mutation of this receptor has been established in the mouse germline. Mice homozygous for this receptor mutation should be useful in understanding the MIS signalling pathway for Müllerian duct regression and gonadal function.Keywords
This publication has 18 references indexed in Scilit:
- Variants of the anti-Müllerian hormone gene in a compound heterozygote with the persistent Müllerian duct syndrome and his familyHuman Genetics, 1992
- Male development of chromosomally female mice transgenic for SryNature, 1991
- Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome.Proceedings of the National Academy of Sciences, 1991
- A Frameshift Mutation Destabilizes Androgen Receptor Messenger RNA in theTfmMouseMolecular Endocrinology, 1991
- A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genesNature, 1990
- Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumpingNature, 1990
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locusCell, 1990
- Mullerian-Inhibiting SubstancePublished by Springer Nature ,1990
- Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cellsCell, 1986
- FREEMARTINS IN CATTLE: THE FIRST STEPS OF SEXUAL ORGANOGENESISReproduction, 1972